CIK: 0001056807 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $2,453,567 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $771,683 | 31.5% | $6.29 | +585.5% | CLASS A ORD | 61559X104 |
| AXSM | AXSOME THERAPEUTICS INC | 1,690,221 | $197,130 | 8.0% | $85.51 | +33.2% | COM | 05464T104 |
| RVMD | REVOLUTION MEDICINES INC | 4,982,384 | $176,177 | 7.2% | $31.23 | +30.0% | COM | 76155X100 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $141,278 | 5.8% | $32.15 | +13.4% | COM | 501575104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,796,513 | $125,983 | 5.1% | $27.38 | +72.1% | COM | 604749101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,575,015 | $124,528 | 5.1% | $24.54 | +70.8% | COM | 74366E102 |
| GHRS | GH RESEARCH PLC | 8,827,712 | $97,370 | 4.0% | $18.98 | -41.1% | ORDINARY SHARES | G3855L106 |
| XOMA | XOMA ROYALTY CORPORATION | 2,983,026 | $59,452 | 2.4% | $15.57 | +54.6% | COM NEW | 98419J206 |
| IONS | IONIS PHARMACEUTICALS INC | 1,913,385 | $57,727 | 2.4% | $32.75 | 0.0% | COM | 462222100 |
| ZYME | ZYMEWORKS INC | 4,308,935 | $51,319 | 2.1% | $7.03 | +94.1% | COM | 98985Y108 |
| KURA | KURA ONCOLOGY INC | 7,754,129 | $51,177 | 2.1% | $9.83 | -20.7% | COM | 50127T109 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $43,533 | 1.8% | $20.31 | -52.7% | COM | 230031106 |
| ACIU | AC IMMUNE SA | 19,822,436 | $37,068 | 1.5% | $4.49 | -43.9% | SHS | H00263105 |
| TYRA | TYRA BIOSCIENCES INC | 3,944,194 | $36,681 | 1.5% | $16.23 | -20.3% | COM | 90240B106 |
| GLPG | GALAPAGOS NV | 1,454,422 | $36,535 | 1.5% | $38.91 | — | SPON ADR | 36315X101 |
| CELC | CELCUITY INC | 3,466,000 | $35,041 | 1.4% | $16.73 | -32.4% | COM | 15102K100 |
| — | VERVE THERAPEUTICS INC | 6,904,050 | $31,552 | 1.3% | $8.34 | — | COM | 92539P101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,771,417 | $30,663 | 1.2% | $34.21 | — | SPONSORED ADS | 86366E106 |
| XNCR | XENCOR INC | 2,740,141 | $29,155 | 1.2% | $20.61 | -19.8% | COM | 98401F105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 5,660,132 | $26,263 | 1.1% | $6.80 | -9.9% | COM | 61225M102 |
| SEPN | SEPTERNA INC | 4,396,124 | $25,454 | 1.0% | $18.24 | -37.4% | COM | 81734D104 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $21,334 | 0.9% | $4.95 | -16.9% | COM | 28617K101 |
| — | CIDARA THERAPEUTICS INC | 924,642 | $19,917 | 0.8% | $16.88 | — | COM NEW | 171757206 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,295,893 | $19,913 | 0.8% | $37.66 | -86.6% | COM | 68062P106 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 696,555 | $19,497 | 0.8% | $15.71 | +22.7% | COM | 697947109 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $19,352 | 0.8% | $5.96 | -23.5% | COM | 344174107 |
| — | ITEOS THERAPEUTICS INC | 3,075,000 | $18,358 | 0.7% | $7.26 | — | COM | 46565G104 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,561,289 | $14,733 | 0.6% | $13.94 | -66.2% | COM | 35104E100 |
| — | ESSA PHARMA INC | 8,748,629 | $13,823 | 0.6% | $3.65 | — | COM NEW | 29668H708 |
| ANNX | ANNEXON INC | 7,000,000 | $13,510 | 0.6% | $2.47 | +34.5% | COM | 03589W102 |
| VSTM | VERASTEM INC | 2,100,468 | $12,666 | 0.5% | $6.35 | -3.7% | COM NEW | 92337C203 |
| — | RAPT THERAPEUTICS INC | 9,237,556 | $11,270 | 0.5% | $1.58 | — | COM | 75382E109 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $10,188 | 0.4% | $19.56 | — | COM | 760273102 |
| IMUX | IMMUNIC INC | 8,902,972 | $9,704 | 0.4% | $1.30 | -16.9% | COM | 4525EP101 |
| AVTX | AVALO THERAPEUTICS INC | 1,036,679 | $8,304 | 0.3% | $10.33 | -26.7% | COM NEW | 05338F306 |
| — | THIRD HARMONIC BIO INC | 2,372,933 | $8,234 | 0.3% | $16.07 | — | COM | 88427A107 |
| — | VIGIL NEUROSCIENCE INC | 4,013,633 | $7,144 | 0.3% | $5.09 | — | COM | 92673K108 |
| TCRX | TSCAN THERAPEUTICS INC | 4,889,474 | $6,747 | 0.3% | $2.48 | -12.7% | COM | 89854M101 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $5,511 | 0.2% | $9.66 | — | ADS | 60853G106 |
| — | IKENA ONCOLOGY INC | 4,006,564 | $5,128 | 0.2% | $12.00 | — | COM | 45175G108 |
| FBRX | FORTE BIOSCIENCES INC | 594,282 | $4,612 | 0.2% | $11.57 | +2.0% | COM NEW | 34962G208 |
| — | ALLAKOS INC | 16,552,417 | $3,767 | 0.2% | $3.39 | — | COM | 01671P100 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $3,324 | 0.1% | $5.34 | -85.5% | COM | 23284F105 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $2,224 | 0.1% | $3.62 | +77.1% | COM NEW | 88032L605 |
| IVA | INVENTIVA SA | 686,040 | $2,058 | 0.1% | $13.70 | — | ADS | 46124U107 |
| — | GLYCOMIMETICS INC | 9,544,262 | $2,004 | 0.1% | $4.18 | — | COM | 38000Q102 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $1,239 | 0.1% | $5.51 | -58.4% | COM NEW | 78397T202 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 59,065 | $1,209 | 0.0% | $22.23 | 0.0% | ORDINARY SHARES | N62509109 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $1,202 | 0.0% | $4.24 | -85.5% | COM | 690469101 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $605 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $221 | 0.0% | $5.07 | — | COM NEW | H57830137 |